Search for: "Teva Pharmaceuticals v. FDA, et al"
Results 61 - 80
of 101
Sort by Relevance
|
Sort by Date
19 Apr 2010, 5:23 am
" Millennium Pharmaceuticals Inc. et al v. [read post]
7 Apr 2010, 4:30 am
Sandoz Pharmaceuticals GmbH et al (EPLAW) Prilosec (Omeprazole) – US: AstraZeneca ordered to pay attorney’s fees for ‘baseless’ suit to protect Prilosec OTC: AstraZeneca AB et al. v. [read post]
24 Mar 2010, 4:45 am
Lupin Ltd. et al. [read post]
18 Mar 2010, 2:30 am
Teva Pharmaceuticals USA, Inc. et al. and Gilead Sciences, Inc., et al. v. [read post]
10 Mar 2010, 5:22 am
Teva Pharmaceuticals USA, Inc. et al (Patent Docs) [read post]
10 Mar 2010, 5:22 am
Teva Pharmaceuticals USA, Inc. et al (Patent Docs) [read post]
3 Mar 2010, 5:05 am
Assistance Publique - Hopitaux De Paris et al. [read post]
3 Mar 2010, 5:05 am
Assistance Publique - Hopitaux De Paris et al. [read post]
17 Feb 2010, 5:10 am
Actavis Elizabeth LLC, et al. [read post]
10 Feb 2010, 4:47 pm
Teva Pharmaceutical Industries Ltd. et al. [read post]
3 Feb 2010, 2:00 am
Johnson & Johnson Inc. et al. [read post]
27 Jan 2010, 3:00 am
Lupin Ltd. concerning LoSeasonique and Takeda Pharmaceutical Company Limited et al v. [read post]
21 Jan 2010, 1:00 am
Teva Parenteral Medicines Inc. et al. [read post]
6 Jan 2010, 3:32 am
Ipsen Pharma, S.A.S. et al. [read post]
16 Dec 2009, 3:39 am
Perrigo Co. et al. [read post]
9 Dec 2009, 3:59 pm
Teva Pharmaceuticals USA Inc. et al. [read post]
18 Nov 2009, 4:57 am
Teva Pharmaceuticals USA Inc. et al. [read post]
18 Nov 2009, 4:57 am
Teva Pharmaceuticals USA Inc. et al. [read post]
18 Nov 2009, 4:57 am
Teva Pharmaceuticals USA Inc. et al. [read post]
9 Sep 2009, 7:14 am
(America-Israel Patent Law) Avinza (Morphine) – US: King Pharmaceuticals, Elan files patent infringement suit against Sandoz in response to Para IV challenge (Patent Docs) Cipro (Ciprofloxacin) – US: California court rules that Bayer AG et al did not violate state antitrust law in Cipro reverse payment case (FDA Law Blog) Effexor (Venlafaxine) - Israel: Patent oppositions: should substance or procedural issues win out? [read post]
